15 employees
Caprico Biotechnologies provides flow cytometry reagents and services for basic research, clinical research, and clinical diagnostic.
2013
Caprico Biotechnologies, Inc. raised undisclosed on September 18, 2023
Investors: Yabao Pharmaceutical Group Co., Ltd.